FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

31007911000001104: Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Dec 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1735161000001116 Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1735171000001114 Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Ceftolozane 1g / Tazobactam 500mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Tazobactam sodium true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Ceftolozane sulfate false Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tazobactam true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ceftolozane true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Is a Zerbaxa true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has active ingredient Tazobactam true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has basis of strength substance Tazobactam true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has basis of strength substance Ceftolozane true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has specific active ingredient Ceftolozane sulfate true Inferred relationship Existential restriction modifier
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) 10 vial Has AMP True Zerbaxa 1g/0.5g powder for concentrate for solution for infusion vials (Merck Sharp & Dohme (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start